Mallinckrodt Public Limited Company (MNK) - 6 Year Stock Split History

Historical stock splits for Mallinckrodt Public Limited Company since 2012. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.011B $3.222B
Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt Plc. is based in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $58.790B 10.34
Teva Pharmaceutical Industries (TEVA) Israel $23.449B 6.13
Mylan (MYL) United Kingdom $18.371B 7.76
Dr Reddy's Laboratories (RDY) India $4.850B 28.96
Supernus Pharmaceuticals (SUPN) United States $2.810B 35.23
Akorn (AKRX) United States $2.168B 10.75
AxoGen (AXGN) United States $1.908B 0.00
Assembly Biosciences (ASMB) United States $0.846B 0.00
Homology Medicines (FIXX) United States $0.802B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.776B 72.35
CymaBay Therapeutics (CBAY) United States $0.752B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.732B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.619B 0.00
Voyager Therapeutics (VYGR) United States $0.593B 0.00
Corium (CORI) United States $0.288B 0.00
Teligent (TLGT) United States $0.215B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.141B 0.00
Sol-Gel Technologies (SLGL) Israel $0.130B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.075B 0.00
Versartis (VSAR) United States $0.072B 0.00
Aevi Genomic Medicine (GNMX) United States $0.054B 0.00
Evoke Pharma (EVOK) United States $0.045B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.029B 0.00
Acasti Pharma (ACST) Canada $0.020B 0.00
Agile Therapeutics (AGRX) United States $0.017B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00